BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1430 related articles for article (PubMed ID: 15583825)

  • 21. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells.
    Pizer ES; Wood FD; Pasternack GR; Kuhajda FP
    Cancer Res; 1996 Feb; 56(4):745-51. PubMed ID: 8631008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.
    Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA
    Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
    Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T
    Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
    Thupari JN; Pinn ML; Kuhajda FP
    Biochem Biophys Res Commun; 2001 Jul; 285(2):217-23. PubMed ID: 11444828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells.
    Brusselmans K; De Schrijver E; Verhoeven G; Swinnen JV
    Cancer Res; 2005 Aug; 65(15):6719-25. PubMed ID: 16061653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
    Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival.
    Chajès V; Cambot M; Moreau K; Lenoir GM; Joulin V
    Cancer Res; 2006 May; 66(10):5287-94. PubMed ID: 16707454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
    Zhou W; Han WF; Landree LE; Thupari JN; Pinn ML; Bililign T; Kim EK; Vadlamudi A; Medghalchi SM; El Meskini R; Ronnett GV; Townsend CA; Kuhajda FP
    Cancer Res; 2007 Apr; 67(7):2964-71. PubMed ID: 17409402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
    Ruiz-Ruiz MC; López-Rivas A
    Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
    Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
    Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conversion of Fas-resistant to Fas-sensitive MCF-7 breast cancer cells by the synergistic interaction of interferon-gamma and all-trans retinoic acid.
    Danforth DN; Zhu Y
    Breast Cancer Res Treat; 2005 Nov; 94(1):81-91. PubMed ID: 16136269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model.
    Pflug BR; Pecher SM; Brink AW; Nelson JB; Foster BA
    Prostate; 2003 Nov; 57(3):245-54. PubMed ID: 14518031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.
    Pizer ES; Jackisch C; Wood FD; Pasternack GR; Davidson NE; Kuhajda FP
    Cancer Res; 1996 Jun; 56(12):2745-7. PubMed ID: 8665507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of p53 in regulating constitutive and X-radiation-inducible CD95 expression and function in carcinoma cells.
    Sheard MA; Uldrijan S; Vojtesek B
    Cancer Res; 2003 Nov; 63(21):7176-84. PubMed ID: 14612511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells.
    Menendez JA; Lupu R
    Arch Immunol Ther Exp (Warsz); 2004; 52(6):414-26. PubMed ID: 15577743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
    Rabi T; Wang L; Banerjee S
    Breast Cancer Res Treat; 2007 Jan; 101(1):27-36. PubMed ID: 17028990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel synthetic triterpenoid methyl 25-hydroxy-3-oxoolean-12-en-28-oate induces apoptosis through JNK and p38 MAPK pathways in human breast adenocarcinoma MCF-7 cells.
    Rabi T; Banerjee S
    Mol Carcinog; 2008 Jun; 47(6):415-23. PubMed ID: 18058803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
    Weng MS; Ho CT; Ho YS; Lin JK
    Toxicol Appl Pharmacol; 2007 Jan; 218(2):107-18. PubMed ID: 17182072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase.
    Zeng L; Biernacka KM; Holly JM; Jarrett C; Morrison AA; Morgan A; Winters ZE; Foulstone EJ; Shield JP; Perks CM
    Endocr Relat Cancer; 2010 Jun; 17(2):539-51. PubMed ID: 20356977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.